SCHEDULE 13G/A: T. Rowe Price Associates Discloses 6.3% Stake in DENTSPLY SIRONA INC
Beneficial Ownership Report (Schedule 13G/A)
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.3% in DENTSPLY SIRONA INC as of December 31, 2024.
Summary
- T. Rowe Price Associates, Inc. (the "Reporting Person") filed a Schedule 13G/A with the SEC regarding its ownership in DENTSPLY SIRONA INC.
- As of December 31, 2024, T. Rowe Price Associates, Inc. beneficially owned an aggregate of 12,549,242 shares of DENTSPLY SIRONA INC's common stock.
- This ownership represents 6.3% of the outstanding common stock of DENTSPLY SIRONA INC.
- The Reporting Person holds sole voting power over 12,504,509 shares and sole dispositive power over 12,549,242 shares.
- No shared voting or dispositive power was reported.
- T. Rowe Price Associates, Inc. is classified as an Investment Adviser (IA) for the purpose of this filing.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, inherently neutral in sentiment regarding the issuer's performance or outlook. It simply reports a significant stake by an institutional investor.
Future Outlook
NA
Industry Context
This filing is a standard disclosure by a large institutional investor, T. Rowe Price Associates, Inc., indicating its significant passive stake in DENTSPLY SIRONA INC. It does not provide specific industry trends or competitive analysis but highlights the continued interest of major asset managers in the dental products and technologies sector.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which can influence market perception and liquidity. The presence of a large, passive institutional holder like T. Rowe Price can be viewed positively as a vote of confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date). |
| 02/14/2025 | Date the Schedule 13G/A was signed by T. Rowe Price Associates, Inc. |
Keywords
DENTSPLY SIRONA INC, T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.